(17-alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

18 Suppliers, 10 USDMF, 6 CEP/COS, 4 NDC API, 9 Listed Suppliers

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Imports

DOSSIERs // Finished Dosage Forms

64 Dossiers, 40 FDA Orange Book, 18 Canada, 3 South Africa, 3 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL-28 - 0.035MG;0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL-28 - 0.035MG,0.035MG,0.035MG;0.18MG,0.215MG,0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL-28 - 0.025MG,0.025MG,0.025MG;0.18MG,0.215MG,0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

MARKET PLACE

1 APIs

1 APIs

ANALYTICAL SOLUTION(s)

1 BioAnalytical Methods, 2 EDQM Standards, 2 USP Standards, 3 Other Ref. Standards

DIGITAL CONTENT

13 News

13 News

(17-alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime
South Africa
Full Screen View

Drug Approvals by the Medicines Control Council in South Africa containing (17-alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime. Original Data : South African Medicines Price Registry

(17-alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

18 Suppliers

10 USDMF

6 CEP/COS

4 NDC API

9 Listed Suppliers

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Imports

DOSSIERs // Finished Dosage Forms

64 Dossiers

40 FDA Orange Book

18 Canada

3 South Africa

3 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL-28 - 0.035MG;0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL-28 - 0.035MG,0.035MG,0.035MG;0.18MG,0.215MG,0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL-28 - 0.025MG,0.025MG,0.025MG;0.18MG,0.215MG,0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

MARKET PLACE

1 APIs

ANALYTICAL SOLUTION(s)

1 BioAnalytical Methods

2 EDQM Standards

2 USP Standards

3 Other Ref. Standards

DIGITAL CONTENT

13 News

(17-alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime

Janssen Pharmaceutica (Pty) Ltd

Norgestimate and estrogen

TAB

20mg/g

Cilest

28X1mg

Originator

South Africa

Janssen Pharmaceutica (Pty) Ltd

Norgestimate and estrogen

CAP

8mg

Reminyl Cr 8Mg

28X1mg

Originator

South Africa

Janssen Pharmaceutica (Pty) Ltd

Norgestimate and estrogen

TAB

10000iu/ml

Tricilest

28X1mg

Originator

South Africa

TABLET;ORAL-28 - 0.035MG;0.25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL-28 - 0.035MG,0.035MG,0.035MG;0.18MG,0.215MG,0.25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL-28 - 0.025MG,0.025MG,0.025MG;0.18MG,0.215MG,0.25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons